Stromal PLAU mediates tumor progression and informs a novel therapeutic target in triple-negative breast cancer

Stromal PLAU mediates tumor progression and informs a novel therapeutic target in triple-negative breast cancer

Abstract Triple-negative breast cancer (TNBC) is an aggressive subtype characterized by limited treatment options and poor prognosis. Recent evidence highlights the crucial role of cancer-associated fibroblasts (CAFs) in TNBC progression, yet their molecular characteristics remain incompletely under...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jun Zou, Jingyao Zhang, Yu Li, Baowen Yuan, Yuanyi Wang, Yalong Qi, Qian Wang, Wan Qin, Xianglin Yuan, Binghe Xu
Format:	Article
Language:	English
Published:	BMC 2025-07-01
Series:	Cancer Cell International
Subjects:	TNBC Cancer-associated fibroblasts Prognostic signature PLAU Tumor microenvironment
Online Access:	https://doi.org/10.1186/s12935-025-03867-y
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Human umbilical cord mesenchymal stem cells ameliorate liver fibrosis by inhibiting hepatocyte ferroptosis and macrophage polarization via the miR-455-3p/PLAU axis
by: Yong Zhang, et al.
Published: (2025-07-01)

PLAU inferred from a correlation network is critical for suppressor function of regulatory T cells
by: Feng He, et al.
Published: (2012-11-01)

Unlocking the secret of glioblastoma multiforme: the role of lactylation in tumor progression, drug resistance and immune microenvironment
by: Yifei Xiao, et al.
Published: (2025-08-01)

A pH and GSH dual responsive nanoparticle co-deliver Adriamycin and Olaparib enhanced the therapeutic efficacy on triple negative breast cancer
by: Maidong Li, et al.
Published: (2025-08-01)

Identification and analysis of diverse programmed cell death patterns in idiopathic pulmonary fibrosis using microarray-based transcriptome profiling and single-nucleus RNA sequencing
by: Jiazheng Sun, et al.
Published: (2025-06-01)

Identification of anoikis-related subtypes and a risk score prognosis model, the association with TME landscapes and therapeutic responses in hepatocellular carcinoma
by: Xiangyu Zhai, et al.
Published: (2025-06-01)

A novel 5-protein kinase risk signature for predicting glioma prognosis and immunotherapy responsiveness
by: Senbin Wu, et al.
Published: (2025-07-01)

Novel ATR/PARP1 Dual Inhibitors Demonstrate Synergistic Antitumor Efficacy in Triple‐Negative Breast Cancer Models
by: Yuan Gao, et al.
Published: (2025-08-01)

Characterization of Cuproptosis-Related LncRNAs Prognostic Signature and Identification of LINC02285 as a Novel Biomarker for Ovarian Cancer
by: Lei H, et al.
Published: (2025-06-01)

Metastatic Triple Negative Breast Cancer: The New Era of Thinking
by: Mohammed Amrallah A., et al.
Published: (2021-05-01)

SUMOylation-regulated genes in colon cancer: expression patterns and clinical implications
by: Wen Peng, et al.
Published: (2025-05-01)

Decoding breast cancer heterogeneity: a novel three-gene signature links intratumoral heterogeneity with tumor microenvironment and patient outcomes
by: Fangfang Zhu
Published: (2025-07-01)

Identification of epithelial-mesenchymal transition prognostic signature associated with prognosis, tumor microenvironment, and therapeutic effect in prostate cancer
by: Yiyuan Li, et al.
Published: (2025-08-01)

Exploration of Traditional Chinese Medicine Comprehensive Treatment of Triple Negative Breast Cancer Based on Molecular Pathological Mechanism
by: Zhu M, et al.
Published: (2025-04-01)

Palmitoylation-driven immune dysregulation and prognostic signature in low-grade glioma: a multi-omics and functional validation study
by: Zehao Wang, et al.
Published: (2025-06-01)

Construction and validation of acetylation-related gene signatures for immune landscape analysis and prognostication risk prediction in luminal breast cancer
by: Mengdi Zhu, et al.
Published: (2025-07-01)

Knowledge mapping of ultrasound technology and triple-negative breast cancer: a visual and bibliometric analysis
by: Yonglin Wan, et al.
Published: (2025-07-01)

An integrative analysis combining bioinformatics, network pharmacology and experimental methods identified key genes of EGCG targets in Nasopharyngeal Carcinoma
by: Yuhang Yang, et al.
Published: (2025-05-01)

Metastatic triple-negative breast cancer – current treatment strategies in the Nordics: a modified Delphi study
by: Antonis Valachis, et al.
Published: (2025-03-01)

Tumor Microenvironment On‐A‐Chip and Single‐Cell Analysis Reveal Synergistic Stromal–Immune Crosstalk on Breast Cancer Progression
by: Kalpana Ravi, et al.
Published: (2025-04-01)

Hypoxia-related signatures predicts survival, immunosuppression and PARP inhibitor resistance in HCC
by: Min Su, et al.
Published: (2025-06-01)

Disulfidptosis-related LncRNAs forecast the prognosis of acute myeloid leukemia
by: Pei Xu, et al.
Published: (2025-04-01)

Multi-omics-based construction of a palmitoylation-driven prognostic model reveals tumor immune phenotypes in osteosarcoma
by: Jingyu Chen, et al.
Published: (2025-08-01)

Duku peel ethyl acetate extract as an adjunctive treatment of doxorubicin on triple negative breast cancer 4T1 cells
by: Faaza Aulia Rahman, et al.
Published: (2025-03-01)

The immune-related prognostic gene AIM2 promotes pancreatic cancer progression via inflammasome
by: Lin Liang, et al.
Published: (2025-08-01)

Inhibition of ATG5-mediated autophagy maintains PMAIP1 stability to promote cell apoptosis and suppress triple-negative breast cancer progression
by: Fangjian Shang, et al.
Published: (2025-05-01)

Predicting immunotherapy prognosis and targeted therapy sensitivity of colon cancer based on a CAF-related molecular signature
by: Leqian Ying, et al.
Published: (2025-02-01)

Leveraging a disulfidptosis-based signature to characterize heterogeneity and optimize treatment in multiple myeloma
by: Bingxin Zhang, et al.
Published: (2025-04-01)

Construction and immunohistochemical validation of a necroptosis-related prognostic signature in bladder cancer and its association with tumor immune infiltration
by: Tao Wang, et al.
Published: (2025-08-01)

POC1A induces epithelial–mesenchymal transition to promote growth and metastasis through the STAT3 signaling pathway in triple-negative breast cancer
by: Yuzhou Qian, et al.
Published: (2025-08-01)

Improved Efficacy of Triple‐Negative Breast Cancer Immunotherapy via Hydrogel‐Based Co‐Delivery of CAR‐T Cells and Mitophagy Agonist
by: Guodong Li, et al.
Published: (2025-04-01)

A novel prognostic signature based on m5C‑related LncRNAs and its immunological characteristics in colon adenocarcinoma
by: Zihe Liu, et al.
Published: (2025-03-01)

HDAC2‐Mediated METTL3 Delactylation Promotes DNA Damage Repair and Chemotherapy Resistance in Triple‐Negative Breast Cancer
by: Xiaoniu He, et al.
Published: (2025-04-01)

Indian medicinal phytocompounds for targeting apoptosis and high-penetrance genes in triple-negative breast cancer: an in-silico exploration
by: Reshmi Kumari, et al.
Published: (2025-07-01)

Development of Multifunctional Targeted Dual-Loaded Polymeric Nanoparticles for Triple-Negative Breast Cancer Treatment
by: Gantumur Battogtokh, et al.
Published: (2025-03-01)

Identification and validation of a lenvatinib resistance-related prognostic signature in HCC, in which PFKFB4 contributes to tumor progression and lenvatinib resistance
by: Jinfeng Wang, et al.
Published: (2025-04-01)

USP51/GRP78/ABCB1 axis confers chemoresistance through decreasing doxorubicin accumulation in triple-negative breast cancer cells
by: Yang Ou, et al.
Published: (2025-05-01)

Metformin-Based Combination Approaches for Triple-Negative Breast Cancer
by: Zaid Sirhan, et al.
Published: (2025-04-01)

Molecular genetic predictors of progression of triple negative breast cancer
by: I. S. Panchenko, et al.
Published: (2025-03-01)

Tumor-derived exosomal lncRNA SNHG4 promotes triple-negative breast cancer progression by targeting XPO5
by: Zhi-Wen Wang, et al.
Published: (2025-06-01)